Ryuichi Furuya

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Simplified nutritional screening tools for patients on maintenance hemodialysis

Kohsuke Yamada, Ryuichi Furuya, Takako Takita et al. · American Journal of Clinical Nutrition · 2008 · 591 citations

Medicine, Nephrology, Nutritional Sciences +14

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients

Mari Odamaki, Ryuichi Furuya, Sakae Ohkawa et al. · Nephrology Dialysis Transplantation · 1999 · 82 citations · Full text

Medicine, Nephrology, Nutritional Sciences +16